Marino, S., Petrusca, D. N., Bishop, R. T., Anderson, J. L., Sabol, H. M., Ashby, C., Layer, J. H., Cesarano, A., Davé, U. P., Perna, F., Delgado-Calle, J., Chirgwin, J. M. and Roodman, G. D. (2024) “Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma”, Haematologica. Pavia, Italy, 109(5), pp. 1501-1513. doi: 10.3324/haematol.2023.283787.